Cheryl Brown

Dr. Cheryl Brown is a Grant-Funded Researcher (B) at the University of Adelaide's School of Biomedicine, within the Faculty of Health and Medical Sciences. She holds appointments at the Women's and Children's Hospital and the Robinson Research Institute. Her primary research focuses on regulatory T-cell biology, cancer mechanisms, and translational regulation, with a particular interest in epigenetic and genomic approaches to understanding immune function and disease.

Education

• PhD in Biomedicine, University of Adelaide (1992–1996)
• MSc in General and Medical Microbiology, University College London (1990–1991)

Research Interests

Dr. Brown's work spans immunology, cancer biology, and molecular mechanisms. Key areas include T-cell plasticity in autoimmune diseases, FOXP3 regulation in regulatory T cells, epigenetic control of gene expression, and the impact of microbiota on health. Her lab employs cutting-edge techniques such as chromatin conformation capture, single-cell profiling, and microRNA analysis to dissect these processes.

Publications

Her recent work highlights contributions to understanding regulatory T cell dynamics in type 1 diabetes, breast cancer progression mediated by microRNAs, and gut microbiota analysis methodologies. These studies underscore translational insights into immune disorders and cancer biology.

Awards & Grants

No specific awards are listed, but her grant-funded position indicates sustained research support. She is eligible to supervise Master's and PhD students, focusing on mentorship in immunology and molecular biology.

Labs & Collaborations

Her affiliations with the Women's and Children's Hospital and Robinson Research Institute enable multidisciplinary collaborations in clinical and basic science research. Previous postdoctoral work at the Fred Hutchinson Cancer Research Center (USA) and University of Washington further enriched her expertise in translational cancer research and apoptosis pathways.